Biblio
Export 2045 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is M [Clear All Filters]
“The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.”, J Alzheimers Dis, vol. 60, no. 3, pp. 819-828, 2016.
, “Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1181-9, 2016.
, “Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1181-9, 2016.
, “Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 451-61, 2016.
, “Association of Frontotemporal Dementia GWAS Loci with Late-Onset Alzheimer's Disease in a Northern Han Chinese Population.”, J Alzheimers Dis, vol. 52, no. 1, pp. 43-50, 2016.
, “Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1597-608, 2016.
, “Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus.”, J Alzheimers Dis, vol. 52, no. 1, pp. 161-9, 2016.
, “Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers.”, J Alzheimers Dis, vol. 53, no. 2, pp. 621-30, 2016.
, “Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.”, J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
, “Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1395-1408, 2016.
, “Associations between Serum Omega-3 Fatty Acid Levels and Cognitive Functions among Community-Dwelling Octogenarians in Okinawa, Japan: The KOCOA Study.”, J Alzheimers Dis, vol. 51, no. 3, pp. 857-66, 2016.
, “Astrocytes release HspB1 in response to amyloid-β exposure in vitro.”, J Alzheimers Dis, vol. 49, no. 1, pp. 251-63, 2016.
, “Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.”, J Alzheimers Dis, vol. 54, no. 3, pp. 941-955, 2016.
, “Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1215-25, 2016.
, “Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1215-25, 2016.
, “Autobiographical Memory Performance in Alzheimer's Disease Depends on Retrieval Frequency.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1215-25, 2016.
, “Bacterial Amyloid and DNA are Important Constituents of Senile Plaques: Further Evidence of the Spirochetal and Biofilm Nature of Senile Plaques.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1459-73, 2016.
, “Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1325-40, 2016.
, “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
, “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
, “Biochemical and Radiological Markers of Alzheimer's Disease Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 623-44, 2016.
, “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
, “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
, “Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.”, J Alzheimers Dis, vol. 54, no. 1, pp. 307-24, 2016.
, “Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 161-74, 2016.
,